Emmerson PLC (EML.L)
GBp 0.61
(-2.4%)
GBp 0.61
(-2.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.6 Million | -4.33 Million | -2.35 Million | -958.06 Thousand | -1.2 Million | -1.47 Million |
| Net Income | -2.4 Million | -3.19 Million | -2.77 Million | -2.07 Million | -1.48 Million | -2.26 Million |
| Depreciation & Amortization | 15.28 Thousand | -2000.00 | 5000.00 | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 335 Thousand | 256 Thousand | 33 Thousand | 991 Thousand | 205.85 Thousand | 290.57 Thousand |
| Change in working capital | -497.16 Thousand | -1.21 Million | 831 Thousand | 55.87 Thousand | 72.11 Thousand | -591.31 Thousand |
| Other non-cash items | 233.29 Thousand | -185 Thousand | -448 Thousand | 1.74 | 0.17 | 1.08 Million |
| Investing Cash Flow | -1.39 Million | -5.05 Million | -2.7 Million | -2.68 Million | -3.23 Million | -1.36 Million |
| Investments in PPE | -1.39 Million | -5.05 Million | -2.67 Million | -2.68 Million | -3.24 Million | -1.59 Million |
| Acquisitions | - | - | - | - | 2000.00 | 229.67 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -30 Thousand | - | 622.33 | 0.11 |
| Financing Cash Flow | 181 Thousand | 5.86 Million | 13.54 Million | 2.21 Million | 2.8 Million | 6.66 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 181 Thousand | 6.13 Million | 14.95 Million | 2.21 Million | 2.14 Million | 5.25 Million |
| Other Financing Activities | - | -267 Thousand | -1.41 Million | - | 666.82 Thousand | 6.66 Million |
| Accounts receivables | 81.25 Thousand | -332.85 Thousand | -255.21 Thousand | -43 Thousand | 81 Thousand | -139 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -578.41 Thousand | -880.14 Thousand | 1.08 Million | 98.87 Thousand | -8886.00 | -327 Thousand |
| Cash at beginning of period | 5.54 Million | 10.03 Million | 1.56 Million | 2.82 Million | 4.39 Million | 529.13 Thousand |
| Cash at end of period | 1.51 Million | 6.67 Million | 10.03 Million | 1.55 Million | 2.71 Million | 4.25 Million |
| Capital Expenditure | -1.39 Million | -5.05 Million | -2.67 Million | -2.68 Million | -3.24 Million | -1.59 Million |
| Effect of forex changes on cash | 13 Thousand | 160 Thousand | -16 Thousand | 167.62 Thousand | -41.95 Thousand | -98.97 Thousand |
| Net cash flow / Change in cash | -4.02 Million | -3.36 Million | 8.46 Million | -1.26 Million | -1.67 Million | 3.72 Million |
| Free Cash Flow | -3.99 Million | -9.38 Million | -5.02 Million | -3.64 Million | -4.44 Million | -3.07 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -798.00 | -798.00 | -678.50 | -2.4 Million | -678.50 | -817.50 |
| Depreciation & Amortization | 2.50 | 2.50 | 7.00 | 15.28 Thousand | 7.00 | 2.50 |
| Deferred income taxes | - | - | - | - | - | -29.92 |
| Stock-based compensation | 67.50 | 67.50 | 68.00 | 335 Thousand | 68.00 | 99.50 |
| Change in working capital | -115.00 | -115.00 | 112.00 | -497.16 Thousand | 112.00 | -61.50 |
| Other non-cash items | -9.00 | -9.00 | -31.50 | 233.29 Thousand | -31.50 | -319.00 |
| Investing Cash Flow | -109.00 | -109.00 | -606.50 | -1.39 Million | -606.50 | -260.00 |
| Investments in PPE | -1.00 | -1.00 | -3.50 | -1.39 Million | -3.50 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -108.00 | -108.00 | -603.00 | - | -603.00 | -260.00 |
| Financing Cash Flow | 1191.00 | 1191.00 | -2.50 | 181 Thousand | -2.50 | 115.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -2.50 | - | -2.50 | - |
| Common Stock Issuance | - | - | - | 181 Thousand | - | - |
| Other Financing Activities | 1191.00 | 1191.00 | - | - | - | 115.00 |
| Accounts receivables | -115.00 | -115.00 | 112.00 | 81.25 Thousand | 112.00 | -61.50 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | -578.41 Thousand | - | - |
| Cash at beginning of period | - | - | - | 5.54 Million | - | 264.76 |
| Cash at end of period | 227.50 | 227.50 | -1121.00 | 1.51 Million | -1121.00 | -980.74 |
| Capital Expenditure | -1.00 | -1.00 | -3.50 | -1.39 Million | -3.50 | - |
| Effect of forex changes on cash | -2.50 | -2.50 | 11.00 | 13 Thousand | 11.00 | -4.50 |
| Net cash flow / Change in cash | 227.50 | 227.50 | -1121.00 | -4.02 Million | -1121.00 | -1245.50 |
| Free Cash Flow | -853.00 | -853.00 | -526.50 | -3.99 Million | -526.50 | -1096.00 |
PRAXIS
MMND
ONCOZ
MIRZAINT
0R23
CPOF